International Biotechnology Trust (CHIX:IBTL) Net Change in Cash : £-4.98 Mil (TTM As of Feb. 2025)

View and export this data going back to 2015. Start your Free Trial

What is International Biotechnology Trust Net Change in Cash?

Net Change in Cash is calculated as the total of Cash Flow from Operations , Cash Flow from Investing, Cash Flow from Financing, and Effect of Exchange Rate Changes.

International Biotechnology Trust's Net Change in Cash for the six months ended in Feb. 2025 was £-6.19 Mil. Its Net Change in Cash for the trailing twelve months (TTM) ended in Feb. 2025 was £-4.98 Mil.

International Biotechnology Trust Net Change in Cash Historical Data

The historical data trend for International Biotechnology Trust's Net Change in Cash can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

International Biotechnology Trust Net Change in Cash Chart

International Biotechnology Trust Annual Data

Trend

Aug15

Aug16

Aug17

Aug18

Aug19

Aug20

Aug21

Aug22

Aug23

Aug24

Net Change in Cash

Get a 7-Day Free Trial

-18.66

-2.54

-19.66

7.50

42.91

International Biotechnology Trust Semi-Annual Data
	Aug15	Feb16	Aug16	Feb17	Aug17	Feb18	Aug18	Feb19	Aug19	Feb20	Aug20	Feb21	Aug21	Feb22	Aug22	Feb23	Aug23	Feb24	Aug24	Feb25
Net Change in Cash	Get a 7-Day Free Trial															15.78	-8.28	41.70	1.21	-6.19

International Biotechnology Trust Net Change in Cash Calculation

International Biotechnology Trust's Net Change in Cash for the fiscal year that ended in Aug. 2024 is calculated as

Net Change in Cash	=	Cash Flow from Operations	+	Cash Flow from Investing	+	Cash Flow from Financing	+	Effect of Exchange Rate Changes
	=	45.352	+	0	+	-2.198	+	-0.247
	=	42.91

International Biotechnology Trust's Net Change in Cash for the quarter that ended in Feb. 2025

Net Change in Cash = Cash Flow from Operations + Cash Flow from Investing + Cash Flow from Financing + Effect of Exchange Rate Changes

= -2.925 + 0 + -3.393 + 0.132

= -6.19

Net Change in Cash for the trailing twelve months (TTM) ended in Feb. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was £-4.98 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

International Biotechnology Trust Net Change in Cash Related Terms
Thank you for viewing the detailed overview of International Biotechnology Trust's Net Change in Cash provided by GuruFocus.com. Please click on the following links to see related term pages.

International Biotechnology Trust Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » International Biotechnology Trust PLC (CHIX:IBTl) » Definitions » Net Change in Cash

Comparable Companies

LSE:4BB LSE:BVXP LSE:FARN LSE:HVO LSE:AVCT LSE:SCLP LSE:PRTC LSE:OXB LSE:SBTX LSE:OBI VRTX ASX:CSL REGN XKRX:207940 ALNY XBRU:ARGX XBRU:UCB ONC XKRX:068270 BNTX

Traded in Other Exchanges

IBT:UK

Address

1 London Wall Place, London, GBR, EC2Y 5AU

Website

https://www.ibtplc.com

International Biotechnology Trust PLC is an investment trust company. It aims at achieving long-term capital growth by investing in biotechnology and other life sciences companies. It seeks to achieve its objective by investing in a diversified portfolio of companies which has good growth prospects. It focuses on investments in biotechnology companies which are engaged in on drug discovery and development, medical devices companies and healthcare services provider. The invests in various financial instruments such as equities, index-linked securities, debt securities, cash deposits, money market instruments ,and foreign currency exchange transactions. Its revenue comprises of dividend, interest and other income from investment made.

International Biotechnology Trust Headlines